4.5 Article

COVID-19 infection causing residual gastrointestinal symptoms - a single UK centre case series

Related references

Note: Only part of the references are listed.
Article Respiratory System

Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort

David T. Arnold et al.

Summary: The study found that most COVID-19 patients still experienced persistent symptoms and limitations in physical ability during the recovery period, but clinically significant abnormalities in chest radiograph, exercise tests, blood tests, and spirometry were less frequent, especially in patients who did not require supplementary oxygen during their acute infection.

THORAX (2021)

Article Gastroenterology & Hepatology

British Society of Gastroenterology guidelines on the management of irritable bowel syndrome

Dipesh H. Vasant et al.

Summary: This guideline aims to review and summarize current evidence on irritable bowel syndrome (IBS) to inform clinical practice and provide guidance, with specific treatment recommendations based on evidence from a comprehensive search of medical literature. The guideline highlights the efficacy of dietary, pharmacological, and psychological therapies in treating IBS, and provides specific recommendations according to the Grading of Recommendations Assessment, Development, and Evaluation system.
Article Multidisciplinary Sciences

More than 50 long-term effects of COVID-19: a systematic review and meta-analysis

Sandra Lopez-Leon et al.

Summary: This study aimed to identify studies assessing the long-term effects of COVID-19, estimating that 80% of infected patients will develop one or more long-term symptoms, with the most common being fatigue, headache, attention disorder, hair loss, and dyspnea.

SCIENTIFIC REPORTS (2021)

Review Medicine, General & Internal

Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19 A Systematic Review

Tahmina Nasserie et al.

Summary: COVID-19 infection is associated with persistent symptoms such as shortness of breath, fatigue, and insomnia. Current studies on symptom persistence are highly heterogeneous, and future research needs longer follow-up, improved quality, and more standardized designs to accurately quantify risks.

JAMA NETWORK OPEN (2021)

Article Medicine, General & Internal

Gastrointestinal Symptoms Associated With Unfavorable Prognosis of COVID-19 Patients: A Retrospective Study

Rong Chen et al.

FRONTIERS IN MEDICINE (2020)

Review Biochemistry & Molecular Biology

COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms

Peijie Zhong et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Parasitology

COVID-19 gastrointestinal manifestations: a systematic review

Filipe Antonio Franca da Silva et al.

REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2020)

Review Gastroenterology & Hepatology

What Is New in Rome IV

Max J. Schmulson et al.

JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2017)

Article Gastroenterology & Hepatology

Post-infectious irritable bowel syndrome

Marroon Thabane et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2009)

Article Gastroenterology & Hepatology

Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome

M. Thabane et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)

Article Gastroenterology & Hepatology

Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen

John K. Marshall et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)